PRIM&R recently submitted comments in response to the Food and Drug Administration (FDA)’s proposed rule "Institutional Review Board Waiver or…
Read MoreIntegrity and the proper conduct of research are essential for the advancement of science and to maintain continued public trust…
Read MoreExpanded access, which is treatment access to experimental drugs (also referred to as "compassionate use" or "pre-approval access"), has generated…
Read MoreOn May 30, 2018, the four-year Right to Try (RTT) movement culminated in a new federal law, with the stated…
Read More
PRIM&R recently submitted comments in response to the Food and Drug Administration (FDA)’s draft guidance "Pregnant Women: Scientific and Ethical…
Read More